Michael L. Babich
Overview
Michael L. Babich received an average of $3M in total compensation, including $393K in salary, at INSYS Therapeutics from 2013 to 2015.
Source: SEC filing on April 19, 2016.
Related executives
We found seven more executives who work or worked at INSYS Therapeutics.
Saeed Motahari
INSYS Therapeutics
Chief Executive Officer
Franc Del Fosse
INSYS Therapeutics
General Counsel
Andrew Long
INSYS Therapeutics
Chief Financial Officer
Darryl Baker
INSYS Therapeutics
Chief Financial Officer
Santosh Vetticaden
INSYS Therapeutics
Chief Executive Officer
John Kapoor
INSYS Therapeutics
Chief Executive Officer
Daniel Brennan
INSYS Therapeutics